tirzepatide surmount 3 SURMOUNT-1 three year efficacy outcomes just presented at #ObesityWeek2024 π πSustained weight loss of 22.9% or an average 54lbs over years π½94% reduction in risk of progression to diabetes. Number eli lilly clinical trials tirzepatide
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14










.png)

















